Ijzermans JN - Search Results

1

Hepatocellular carcinoma and liver transplantation: an animal model.

Schotman SN, Schraa EO, Marquet RL, Zondervan PE, Ijzermans JN. Schotman SN, et al. Among authors: ijzermans jn. Transpl Int. 1998;11 Suppl 1:S201-5. doi: 10.1007/s001470050461. Transpl Int. 1998. PMID: 9664979

2

[Cytokines as immunotherapy in cancer].

van der Schelling GP, Ijzermans JN, Marquet RL, Jeekel J. van der Schelling GP, et al. Among authors: ijzermans jn. Ned Tijdschr Geneeskd. 1992 Apr 4;136(14):681-5. Ned Tijdschr Geneeskd. 1992. PMID: 1373229 Review. Dutch. No abstract available.

3

Injection of recombinant tumor necrosis factor directly into liver metastases: an experimental and clinical approach.

IJzermans JN, Scheringa M, van der Schelling GP, Geerling RA, Marquet RL, Jeekel J. IJzermans JN, et al. Clin Exp Metastasis. 1992 Mar;10(2):91-7. doi: 10.1007/BF00114585. Clin Exp Metastasis. 1992. PMID: 1537138 Free article. Clinical Trial.

4

A phase I study of local treatment of liver metastases with recombinant tumour necrosis factor.

van der Schelling GP, IJzermans JN, Kok TC, Scheringa M, Marquet RL, Splinter TA, Jeekel J. van der Schelling GP, et al. Among authors: ijzermans jn. Eur J Cancer. 1992;28A(6-7):1073-8. doi: 10.1016/0959-8049(92)90460-j. Eur J Cancer. 1992. PMID: 1627378 Clinical Trial.

5

Treatment with rIFN-gamma has no effect on cardiac allograft rejection.

Ijzermans JN, Bouwman E, de Bruin RW, Jeekel J, Marquet RL. Ijzermans JN, et al. Immunology. 1991 Jun;73(2):243-5. Immunology. 1991. PMID: 1906427 Free PMC article.

6

Local treatment of liver metastases with recombinant tumour necrosis factor (rTNF): a phase one study.

IJzermans JN, van der Schelling GP, Scheringa M, Splinter TA, Marquet RL, Jeekel J. IJzermans JN, et al. Neth J Surg. 1991 Aug;43(4):121-5. Neth J Surg. 1991. PMID: 1944989

7

Immunomodulation by recombinant rat interferon-gamma in vivo.

IJzermans JN, Bouwman E, Bijma A, Jeekel J, van der Meide PH, Marquet RL. IJzermans JN, et al. J Interferon Res. 1990 Apr;10(2):203-11. doi: 10.1089/jir.1990.10.203. J Interferon Res. 1990. PMID: 2111355

8

Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.

Ijzermans JN, Bouwman E, Jeekel J, Marquet RL. Ijzermans JN, et al. Transplant Proc. 1990 Aug;22(4):1941-2. Transplant Proc. 1990. PMID: 2117821 No abstract available.

9

The antitumour activity of the interferon inducer bropirimine is partially mediated by endogenous tumour necrosis factor alpha.

Scheringa M, IJzermans JN, Jeekel J, Marquet RL. Scheringa M, et al. Among authors: ijzermans jn. Cancer Immunol Immunother. 1990;32(4):251-5. doi: 10.1007/BF01741709. Cancer Immunol Immunother. 1990. PMID: 2261599 Free PMC article.

10

Modulation of the immune response by interferon gamma administration in a rat cardiac allograft model.

Bouwman E, IJzermans JN, vd Meide PH, Schellekens H, de Bruin RW, Marquet RL, Jeekel J. Bouwman E, et al. Among authors: ijzermans jn. Transplant Proc. 1989 Feb;21(1 Pt 1):465-6. Transplant Proc. 1989. PMID: 2495612 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

720 results

Search Page

Filters